Literature DB >> 15706467

Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.

P Kämpf, M W Agelink, D Naber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706467     DOI: 10.1055/s-2005-837772

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  6 in total

Review 1.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Pharmacologic treatment of first-episode schizophrenia: a review of the literature.

Authors:  Shibu P Thomas; Harpal Sing Nandhra; Swaran P Singh
Journal:  Prim Care Companion CNS Disord       Date:  2012-01-05

3.  Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Authors:  Marc Ziegenbein; Georg Wittmann; Stefan Kropp
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 4.  Practical issues with amisulpride in the management of patients with schizophrenia.

Authors:  Luca Pani; José M Villagrán; Vassilis P Kontaxakis; Köksal Alptekin
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

5.  Current perspectives in the treatment of resistant schizophrenia.

Authors:  R K Solanki; Paramjeet Singh; Deepti Munshi
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

6.  Clozapine and co-prescribed psychotropics: a short report.

Authors:  Maneesh Gupta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.